Faces Of Digital Health

John Halamka is the President of the Mayo Clinic Platform and a leading expert in digital health and AI. He has traveled to 21 countries, helping to scale digital health solutions and address regulatory and ethical challenges in the reuse of healthcare data. Addressed topics in this discussion: 1. Differences in regulatory frameworks and cultural expectations across countries. 2. Comparison of the U.S. and European approaches to AI and data exchange. 3. Risks associated with generative AI and the need for a credibility scores. 4. Observations from various countries on AI adoption. Importance of local tuning for algorithm validation. 5. Data Standards and Future Trends. 6. Advice for Governments and Healthcare Institutions: Encouraging a proactive approach to AI adoption -Starting with low-risk projects and building trust and reliability. Website: www.facesofdigitalhealth.com Newsletter: https://fodh.substack.com/ Youtube: https://www.youtube.com/watch?v=tH9qYpFW-W8

You may not have heard about Prenuvo, but you probably know Kim Kardashian. Or perhaps you know about Prenuvo because of Kim Kardashian. Prenuvo offers whole-body MRI scans for $2500. About 3-4% of people get something discovered, 10% have detected changes that require follow-ups. Opinions about the usefulness of these scans are diverse, with some hesitation on the clinical side. At HLTH Europe, the CEO Andrew Lacy explained:

If you ever want to go to a healthcare innovation conference that doesn’t shy away from potentially controversive topics, HLTH is your place to go. In June 2024, the conference, which attracts 12,000 people in the US, came to Europe. At the center of the exhibition hall stood the Heart Stage focused on topics related to women’s health. Around it were the exhibitor booth and other stages, each designed with a different theme, each like a theatre setup that made speakers feel like stars. Why do people love going to HLTH? Because it’s focused on the experience of the attendees in “a little extra” way. The ticket includes meals, music, there were massage and hair salon in the middle of the exhibition floor, lots of evening networking events, from more formal but still unusual ones, such as the Phillips reception in a museum, to the closing evening with a concert by The Libertines. When the experience is good, and festival-live, it attracts people. When people come, you very quicky attract VIPs of the industry, wh

Debates around equity and equality, especially concerning men and women and female representation, can become heated and divisive quickly. For a long time, female bodies have been perceived merely as male bodies with different reproductive organs. However, the differences go beyond that: 80% of people with autoimmune conditions are women, 66% of Alzheimer's disease patients are women, and symptoms of cardiovascular diseases present differently in women and men, among other disparities. These health issues significantly impact women's productivity. In today's episode, you will hear a recording from the Healthcare Business Women Ljubljana meetup focused on women's health. Joy Rios, founder of HIT Like a Girl Media joined the discussion on women's health and how the unique aspects of women's health are impacting digital health companies and businesses. While less than a quarter of CEOs in digital health companies are women, in femtech companies, 76% of founders, co-founders, and CEOs are women. Website: www.

Rome was buzzing with digital health at the end of May as the HIMSS Europe conference took place at La Nuova Congress Center. Delegates from 80 countries and representatives of health ministries of 20 countries marked the event with discussions about the implementation of EHDS, the EU AI Act, and more.  In this episode, a few participants share their impressions from the discussions at the conference and the current state of healthcare digitalization in Europe. You will hear from:  Jordi Piera-Jiménez. Director of the Digital Health Strategy Office, Catalan Health Service, who shared his view and experience on data management and data standards,  Rachel Dunscombe , CEO of openEHR foundation and former the UK AI council member leading on AI in digital health and care, who presented the discussions on AI, Svava María Atladóttir, Executive Director of Development, Landspítali National University Hospital Iceland, about what it takes to build a new hospital which is what she needs to do by 2030,  Nana Odom, D

According to WHO, the global cost associated with medication errors is 42 billion US dollars. Errors can happen at the point of prescribing, transcribing from one system to the other, or administration, when the wrong patient is given either the wrong drug or the wrong dose. Medication administration errors can be prevented with the introduction of closed-loop medication management, where all points of medication handling are connected and done electronically; even medication administration is done with the help of barcode scanning of the patient barcode and medication barcode. Three European specialists from the Netherlands, UK, and Belgium recently started a European project, Asclepius, which advocated for the introduction of closed-loop medication management systems in the hospitals. They connected with colleagues from UK, France, Iceland, Belgium, Norway, Netherlands, Sweden to strive for alignment on the European level. So in today’s discussion, you will hear from Patrick van Oirschot, Patrick Koch and F

The European Health Data Space is around the corner. The legislation is confirmed. How do we get to the next steps? Today you will hear a discussion with Eric Sutherland, Senior Health Economist and Digital Health Lead at OECD, who worked on the pan-Canadian health data strategy before his current role. We discussed the upcoming implementation of the European Health Data Space, what needs to happen next, how do we involve the public, encourage trust in data sharing, and also build capacity for digital health implementation. We are moving into the era of new required data professionals, not just data analysts, but also data controllers, data stewards and more.  www.facesofdigitalhealth.com Newsletter: https://fodh.substack.com/ Show notes: [00:02:00] - Eric Sutherland's background and transition from Canada to OECD [00:04:00] - Challenges and solutions in Canadian health data strategy, emphasizing the need for data stewardship and public engagement [00:06:00] - Importance of data interoperability and policy

AI and predictive modeling to understand an individual’s immune system function and predict treatment response are still in very early stages. We dream about precision medicine and getting every answer we can for ourselves when we get sick. However, if we look at genomics, only about 20 percent of human coding genes are well-studied. The remaining 80 percent (about 16,000 genes, along with the proteins they make) are largely a mystery.  In this episode, you will hear more about the field of immuno-oncology, understand the correlation between tumor development and immune system response, and trends in cancer detection and prevention, especially liquid biopsies - tests for detecting tumors in blood samples.  Speaker: Brian Hashemi - Executive Chairman and CEO of Novigenix - a Swiss-based biotech company using AI and RNA sequence analysis to capture the cancer immunity cycle during the multi-stage disease progression and response to therapy. www.facesofdigitalhealth.com https://fodh.substack.com/ Show notes: [0

The Gulf Cooperation Council (GCC) brings together six Arab countries – Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates  When one reads about the GCC countries, there’s nothing but the impression of prosperity: high investments, determination, and enthusiasm in tech-supported healthcare.  The spending on healthcare by the GCC governments is on an astronomical rise. From a regionwide US$2.4 billion in 2016, it rose to more than US$30 billion in 2021 and is projected to surpass US$104 billion this year, according to a report from the UAE Ministry of Economy.  In this episode, Pilar Fernandez Hermida International Go-to-Market expert with 20+ years of experience launching sales & partner ecosystem strategies, talks about the potential of the Middle East and MENA region for healthtech companies, the culture in the Middle East, how to interpret different style of communication here, what are the common entrepreneurial misconceptions, and where to find opportunities. Pilar says that the ent

In the last few years, we've witnessed a whirlwind of developments in the world of Digital Therapeutics (DTx) - from FDA approvals sparking optimism for the industry, to the establishment of regulatory frameworks in countries like Germany, France, and Belgium. However, in 2023, the industry faced a stark reality check, marked by the fall of some key players and healthcare systems' hesitancy towards embracing and financing these innovations. This turbulence has reshaped strategies and raised critical questions about the future of DTx.

Patient-reported outcomes (PROs) have become increasingly integral in healthcare for assessing the effectiveness of treatments from the patient's perspective. It sounds like a reasonable step in improving clinical research and care provision, but gathering data can be more difficult then you may think. It isn't easy to get to marginalized communities. There are language barriers in collecting data. There are cultural aspects that impact responses. So, how can you design useful electronic solutions for patient-reported outcomes? Hear from Mustafa Ali Syed, Researcher at the Manchester Academic Health Science Centre, The University of Manchester, and Ben James, Co-founder/Chief Design Officer at uMotif - ePRO, an engagement platform designed to power clinical and real-world research. Both are co-authors of a recently published paper titled Exploring the Cross-cultural Acceptability of Digital Tools for Pain Self-reporting. www.facesofdigitalhealth.com Newsletter: https://fodh.substack.com/ Show notes: 00:00:

Did you know that Belgium has had an idea for classifying and validating digital therapeutics since 2018? A clear framework was formed with all main stakeholders involved - from health insurance to the industry. So why are we not hearing more about DTx in Belgium? In this discussion you will hear from Dr. Steven Vandeput -  he is the Advisor for Digital MedTech and Services & Technologies Home Assistance in Belgium; he is managing the mHealthBelgium portal and, since 2019, has been a representative for beMedTech, the sector federation that represents the industry of medical technologies in Belgium.  Website: www.facesofdigitalhealth.com Newsletter: https://fodh.substack.com/ Show notes: 00:00 - Introduction 01:45 - Digital Therapeutics in Belgium 03:50 - Belgium's Healthcare Framework Development 06:00 - The Validation Pyramid and Reimbursement System 08:00 - Fate of Pilot Projects and Their Impact 10:00 - Utilization of mHealth Belgium Portal 12:00 - Challenges in Reimbursement and Financing 14:00 - Prospe

The field of oncology treatments is advancing very fast with innovative therapies and approaches on the market every day. It can get very tricky to support these therapies from an IT perspective, which is what you will hear more about in this discussion. I spoke with Anish Patankar, SVP and GM of Elekta’s Oncology Software Solutions, and we discusses: How to go about the US hospital market,  Development in software for oncology treatments, Challenges in scaling healthcare IT software across markets.  Newsletter: https://fodh.substack.com/ www.facesofdigitalhealth.com Show notes: [00:00:00] Introduction to Elekta [00:02:00] Elekta's Global Presence [00:04:00] US Market Focus [00:06:00] Growth in Developing Countries [00:08:00] Segmentation and Technology Adoption in the US [00:10:00] Untapped Needs and Opportunities in the US [00:12:00] Elekta's Use of AI [00:14:00] Patient Feedback and Clinical Decision Making [00:18:00] Navigating Legacy Software in Healthcare IT [00:20:00] Modernization and Customer

In 2023, Insilico Medicine—a biotech company developing medications with a heavy reliance on AI—used AI to develop an experimental drug for the incurable lung disease idiopathic pulmonary fibrosis. The treatment is in mid-stage trials in the US and China, with some results expected in early 2025. Biotech is one of the fields that has been using generative AI for years, even before ChatGPT brought the technology to public view. Latest technology is essential in drug development. However, the convergence of digital health and pharma seems less clear. Digital health apps started gaining popularity around 2015, and at that time, it seemed all pharma companies were trying to figure out what they could gain from apps, so they financed accelerators and incubators one after the other. We've seen many ideas about how Pharma should or could use digital health. In the last few years, there have been many notorious cases when partnerships failed—a seemingly unicorn, Proteus, which designed digital sensors-equipped pills,

HLTH (https://hlth.com/) is an event where you will see a literal forest on one of the stages, be able to take a selfie with a unicorn mascot, and get perks like hlth branded pink nail polist on your entrance. In the last few years, HLTH has become the most flashy, visible and must-go digital health event in the US. In this episode, Richard Scarfo, president of HLTH, talks about HLTH's approach to making events memorable, why HLTH is taking experience economy as a guiding principle in the investment in the scene at HLTH. You will also hear networking tips, and why HLTH is coming to Europe in June 2024.  HLTH Europe (17-20 June 2024): https://europe.hlth.com/ www.facesofdigitalhealth.com Newsletter: https://fodh.substack.com/

Migraine is 3 times more common in women than in men.  2/3 of patients with Alzheimer’s disease. Gender differences are real and they matter.  The Women's Brain Project (WBP) is a Swiss-based international non-profit organization founded in 2016. It comprises a diverse team of academic and social scientists, medical doctors, engineers, patients, caregivers, artists, and AI experts. The WBP focuses on understanding sex and gender differences in brain and mental diseases to pave the way for precision medicine. This involves tailoring medical treatment to the individual characteristics of each patient, including factors like sex, gender, genomic and proteomics, microbiome, ethnicity, and socio-economic status​​. In this episode Antonella Santuccione Chadha, medical doctor and CEO of Women’s brain project and Anna De, Head of Stakeholder Engagement at Women's Brain Project explain: where are we with data about women’s health specifics, what is driving research in women’s health, what is the negative health and so

Laboratory tests provide doctors with crucial information for diagnosis, monitoring disease progression, evaluating organ function, assessing risk factors for diseases and more. Laboratory testing can be reassuring, however, it is often deemed unnecessary. In this short episode recorded at HLTH, we’re going to talk about laboratory test optimization. How can it be done without undermining clinical autonomy, what kind of real-time insights can be offered to doctors with tech and more. You will hear from Pam Stahl, President of of Avalon Healthcare Solutions - American Lab Insights Company, that help payers and providers optimize treatments, improve outcomes, and drive down overall cost. Newsletter: https://fodh.substack.com/ www.facesofdigitalhealth.com Show notes: [00:02:04] - Introduction to Avalon Health Solutions and their role in generating actionable insights from lab results. [00:02:21] - Discussion on the big picture problem in healthcare: the overuse and underuse of lab tests and the drive towards

In this episode, you’re going hear about the German market for digital health startups, the innovation approach at Charite, one of Europe's largest university hospitals, the challenges with digital therapeutics in Germany and beyond. I spoke with Dorothée Marie-Louise Döpfer, Deputy Head of Digital Labs and program Manager of the Digital Health Accelerator & Community Building at Charite UMC Berlin. Dorothee also shared her expectations about the impact of AI on European health systems.  Newsletter: https://fodh.substack.com/ www.facesofdigitalhealth.com

ePrescribing has become a norm in the US healthcare system. Now, the expanded role of pharmacists and the integration of non-physician prescribers into the healthcare system signifies a move towards a more accessible healthcare model, potentially alleviating some of the clinicians' burdens. Surescripts is the national provider of the ePrescribing infrastructure in the US. In this short discussion, I spoke with Dr. Lynne Nowak, Chief Data and Analytics Officer, and Melanie Marcus, Chief Marketing and Customer Experience Officer at Surescripts, about the importance of ePrescribing on a national level, the changing role of pharmacists, and how it facilitates the redistribution of healthcare provision burdens.  Newsletter: https://fodh.substack.com/ www.facesofdigitalhealth.com

Digital health funding has fallen significantly since 2020. However, funding for Femtech went from 7,6% inside the digital health investments in 2020 to 13,26% in 2022, according to TechCrunch. The awareness about female-specific health-related characteristic has been on the rise for the last several years, which is evident in the growing healthcare innovation space specifically targeting women. In this discussion, you will hear from Marija Butković - founder and CEO of Women of Wearables, a Venture Partner at Simsan Ventures, and an advisor for multiple global organizations in the women's health space. Marija talked about: The challenge of providing appropriate care and support to women (for issues like menstruation, menopause, and conditions like endometriosis) without creating a sense of inequality or sidelining men, data-driven approaches in addressing women's health issues,  trends in women's health for the year 2023, including a broader understanding of fertility issues. Newsletter: https://fodh.su